Progesterone-targeted magnetic resonance imaging probes.
Progesterone-targeted magnetic resonance imaging probes.
复制标题
DOI:
10.1021/bc500265h
复制
发表时间:
2014-08-20
影响因子:
4.7
通讯作者:
Meade, Thomas J.
中科院分区:
文献类型:
--
作者:
Townsend, Taryn R.;Moyle-Heyrman, Georgette;Sukerkar, Preeti A.;MacRenaris, Keith W.;Burdette, Joanna E.;Meade, Thomas J.
Determination of progesterone receptor (PR) status in hormone-dependent diseases is essential in ascertaining disease prognosis and monitoring treatment response. The development of a noninvasive means of monitoring these processes would have significant impact on early detection, cost, repeated measurements, and personalized treatment options. Magnetic resonance imaging (MRI) is widely recognized as a technique that can produce longitudinal studies, and PR-targeted MR probes may address a clinical problem by providing contrast enhancement that reports on PR status without biopsy. Commercially available MR contrast agents are typically delivered via intravenous injection, whereas steroids are administered subcutaneously. Whether the route of delivery is important for tissue accumulation of steroid-modified MRI contrast agents to PR-rich tissues is not known. To address this question, modification of the chemistry linking progesterone with the gadolinium chelate led to MR probes with increased water solubility and lower cellular toxicity and enabled administration through the blood. This attribute came at a cost through lower affinity for PR and decreased ability to cross the cell membrane, and ultimately it did not improve delivery of the PR-targeted MR probe to PR-rich tissues or tumors in vivo. Overall, these studies are important, as they demonstrate that targeted contrast agents require optimization of delivery and receptor binding of the steroid and the gadolinium chelate for optimal translation in vivo.
登录
查看更多内容
影响因子:
7.6
作者:
Meng Q;Li Z
通讯作者:
Li Z
影响因子:
2.4
作者:
Boruban, Melih C.;Altundag, Kadri;Blankstein, Josef
通讯作者:
Blankstein, Josef
DOI:
10.2214/ajr.10.4665
发表时间:
2011-12
期刊:
AJR. American journal of roentgenology
影响因子:
--
作者:
El Khouli RH;Macura KJ;Kamel IR;Jacobs MA;Bluemke DA
通讯作者:
Bluemke DA
影响因子:
120.1
作者:
Leeson, Paul D.;Springthorpe, Brian
通讯作者:
Springthorpe, Brian
DOI:
10.2967/jnumed.112.103465
发表时间:
2012-07
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
Fowler AM;Chan SR;Sharp TL;Fettig NM;Zhou D;Dence CS;Carlson KE;Jeyakumar M;Katzenellenbogen JA;Schreiber RD;Welch MJ
通讯作者:
Welch MJ